Global Publications Senior Manager

Amgen is searching for a Global Publications Senior Manager to join our Cardiovascular and Neuroscience Therapeutic Area team in Thousand Oaks, CA, reporting to a Director of Global Publications. The successful candidate will work with cross-functional and cross-regional leaders to develop dynamic, strategic Global Publication Plans aligned with program objectives for cardiovascular products.

The Senior Manager responsibilities include, but are not limited to:

• Evaluate cross-functional and regional insights and use these to build and maintain a global publication strategy, publication objectives, and publication tactics, in alignment with global product and medical strategies
• Lead global publication planning team meetings and facilitate decision-making on publication priorities
• Manage internal relationships with cross-functional partners and external relationships with authors and corporate partners
• Support transparency commitments by ensuring adherence to disclosure requirements
• Contribute to and/or lead department, functional, and/or cross-functional activities and initiatives
• Facilitate various department processes (eg, congress travel for presenting authors, requests for deviations from the Publications Standard Operating Procedure, copyright permissions)

Additional activities may include:

• Provide on-site support at key scientific congresses and meetings
• Understand the evolving publications landscape through engagement with and participation in professional societies
• Manage execution of publications, including oversight of vendors, as needed
• Travel occasionally (up to 10%)

Basic Qualifications

Doctorate degree and 2 years of publication planning, writing, medical affairs, medical communications, clinical or medical information experience

OR

Master's degree and 6 years of publication planning, writing, medical affairs, medical communications, clinical or medical information experience

OR

Bachelor's degree and 8 years of publication planning, writing, medical affairs, medical communications, clinical or medical information experience

OR

OR
Associate's degree and 10 years of publication planning, writing, medical affairs, medical communications, clinical or medical information experience
OR
High school diploma / GED and 12 years of publication planning, writing, medical affairs, medical communications, clinical or medical information experience

Preferred Qualifications

• PhD, MD, PharmD, with experience in Clinical Development and/or Medical Affairs within the biopharmaceutical industry
• Experience in publication planning
• Clear understanding of current publication environment, good publication practices, Sunshine Act/Pharma Code of Conduct, ICMJE, GPP3, and other global guidelines related to publications, scientific data communication, and transparency standards
• Cardiovascular disease/therapeutic area knowledge
• Demonstrated record of executing strategically and tactically in a highly matrixed environment working successfully with cross-functional, dynamic teams
• Demonstrated ability to provide strategic input to senior leadership and influence decision making
• Excellent communication and interpersonal skills (written, verbal, and presentation) and organizational, time management, and project management/planning skills
• Strong computer and database skills, particularly with Microsoft Office products and Datavision

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

#LI-POST